Correlation Between Kalray SA and Abivax SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kalray SA and Abivax SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalray SA and Abivax SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalray SA and Abivax SA, you can compare the effects of market volatilities on Kalray SA and Abivax SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalray SA with a short position of Abivax SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalray SA and Abivax SA.

Diversification Opportunities for Kalray SA and Abivax SA

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Kalray and Abivax is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Kalray SA and Abivax SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abivax SA and Kalray SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalray SA are associated (or correlated) with Abivax SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abivax SA has no effect on the direction of Kalray SA i.e., Kalray SA and Abivax SA go up and down completely randomly.

Pair Corralation between Kalray SA and Abivax SA

Assuming the 90 days trading horizon Kalray SA is expected to generate 8.82 times more return on investment than Abivax SA. However, Kalray SA is 8.82 times more volatile than Abivax SA. It trades about 0.07 of its potential returns per unit of risk. Abivax SA is currently generating about -0.22 per unit of risk. If you would invest  115.00  in Kalray SA on September 24, 2024 and sell it today you would lose (13.00) from holding Kalray SA or give up 11.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kalray SA  vs.  Abivax SA

 Performance 
       Timeline  
Kalray SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kalray SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Kalray SA is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Abivax SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abivax SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Kalray SA and Abivax SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kalray SA and Abivax SA

The main advantage of trading using opposite Kalray SA and Abivax SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalray SA position performs unexpectedly, Abivax SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abivax SA will offset losses from the drop in Abivax SA's long position.
The idea behind Kalray SA and Abivax SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation